The efficacy of cetuximab in a tissue-engineered three-dimensional in vitro model of colorectal cancer

Journal of Tissue Engineering

Volumn 5, Issue , 2014, Pages

  Magdeldin, Tarig ^a   López Dávila, Víctor ^a   Villemant, Cecile ^b   Cameron, Grant ^b   Drake, Rosemary ^b   Cheema, Umber ^a   Loizidou, Marilena ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SARTORIUS STEDIM BIOTECH GMBH   (Germany)

Author keywords

cetuximab; Collagen; colorectal cancer; drug discovery; epidermal growth factor receptor; plastic compression; three dimensional culture

Indexed keywords

CELL CULTURE; CELL GROWTH; COLLAGEN; DIAGNOSIS; GENE EXPRESSION; GROWTH KINETICS; MONOLAYERS; PHYSIOLOGICAL MODELS; TISSUE;

CETUXIMAB; DRUG DISCOVERY; EPIDERMAL GROWTH FACTOR RECEPTORS; IN-VITRO; IN-VITRO MODELS; MONOLAYER CULTURE; PLASTIC COMPRESSION; PRECLINICAL DEVELOPMENT; THREE-DIMENSIONAL CULTURE; TWO-DIMENSIONAL;

DISEASES;

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CELL AGGREGATION; CELL COUNT; CELL CULTURE TECHNIQUE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THREE DIMENSIONAL CULTURE;

EID: 84963903490     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731414544183     Document Type: Article

References (29)

1. J.FerlayH.R.ShinF.Bray. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide (IARC Cancer Base No. 10). Lyon: International Agency for Research on Cancer, 2010, http://globocan.iarc.fr
2. O.TrédanC.M.GalmariniK.Patel. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst2007; 99(19): 1441–1454.
3. J.G.CromptonD.CleverR.Vizcardo. Reprogramming antitumor immunity. Trends Immunol2014; 35: 178–185.
4. A.PintoM.MerinoP.Zamora. Targeting the endothelin axis in prostate carcinoma. Tumour Biol2012; 33(2): 421–426.
5. J.FriedrichR.EbnerL.A.Kunz-Schughart. Experimental anti-tumor therapy in 3-D: spheroids–old hat or new challenge?Int J Radiat Biol2007; 83(11–12): 849–871.
6. L.A.Kunz-SchughartM.KreutzR.Knuechel. Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int J Exp Pathol1998; 79(1): 1–23.
7. D.L.HollidayK.T.BrouiletteA.Markert. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression. Breast Cancer Res2009; 11(1): R3.
8. S.SuriC.E.Schmidt. Cell-laden hydrogel constructs of hyaluronic acid, collagen, and laminin for neural tissue engineering. Tissue Eng Part A2010; 16(5): 1703–1716.
9. N.A.PeppasJ.Z.HiltA.Khademhosseini. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater2006; 18(11): 1345–1360.
10. G.D.NicodemusS.J.BryantThe role of hydrogel structure and dynamic loading on chondrocyte gene expression and matrix formation. J Biomech2008; 41(7): 1528–1536.
11. D.J.MooneyC.L.MazzoniC.Breuer. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials1996; 17(2): 115–124.
12. E.S.PlaceJ.H.GeorgeC.K.Williams. Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev2009; 38(4): 1139–1151.
13. R.A.BrownM.WisemanC.-B.Chuo. Ultrarapid engineering of biomimetic materials and tissues: fabrication of nano- and microstructures by plastic compression. Adv Funct Mater2005; 15(11): 1762–1770.
14. E.F.DunnM.IidaR.A.Myers. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene2011; 30(5): 561–574.
15. A.Fourest-LieuvinL.PerisV.Gache. Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1. Mol Biol Cell2006; 17: 1041–1050.
16. P.A.KennyG.Y.LeeC.A.Myers. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol2007; 1(1): 84–96.
17. K.M.YamadaE.CukiermanModeling tissue morphogenesis and cancer in 3D. Cell2007; 130(4): 601–610.
18. R.Parenteau-BareilR.GauvinF.BerthodCollagen-based biomaterials for tissue engineering applications. Materials (Basel)2010; 3(3): 1863–1887.
19. V.J.Coulson-ThomasY.M.Coulson-ThomasT.F.Gesteira. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res2011; 346(2): 223–236.
20. A.NygaM.LoizidouM.Emberton. A novel tissue engineered three-dimensional in vitro colorectal cancer model. Acta Biomater2013; 9(8): 7917–7926.
21. E.BurdettF.KasperEngineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B Rev2010; 16(3): 351–359.
22. X.XiangY.PhungM.Feng. The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One2011; 6(1): e14640.
23. S.ChowdhuryM.OngchinE.Sharratt. Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines. PLoS One2013; 8(4): e60299.
24. H.YamaguchiJ.CondeelisRegulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta2007; 1773(5): 642–652.
25. A.PatsialouJ.WyckoffY.WangInvasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res2009; 69(24): 9498–9506.
26. R.WildK.FagerC.Flefleh. Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels. Mol Cancer Ther2006; 5(1): 104–113.
27. A.LièvreJ.-B.BachetD.Le Corre. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res2006; 66(8): 3992–3995.
28. P.Laurent-PuigA.CayreG.Manceau. Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J Clin Oncol2009; 27(35): 5924–5930.
29. Y.-F.HsuD.AjonaL.Corrales. Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Mol Cancer2010; 9(1): 139.